Based on a sample of medicines that faced generic entry in the period from 2000 to 2007, average price levels for medicines decrease by almost 20% after the first year following generic entry.
Selliste ravimite valimi põhjal, millega samaväärsed geneerilised ravimid tulid turule ajavahemikul 2000–2007, tehti kindlaks, et ravimite keskmine hind langes esimesel aastal pärast tululetulekut peaaegu 20 %.